The Tay-Sachs disease gene in North American Jewish populations: geographic variations and origin
- PMID: 6650504
- PMCID: PMC1685967
The Tay-Sachs disease gene in North American Jewish populations: geographic variations and origin
Abstract
From data collected in a North American Tay-Sachs disease (TSD) heterozygote screening program, the TSD carrier frequency among 46,304 Jewish individuals was found to be .0324 (1 in 31 individuals). This frequency is consistent with earlier estimates based on TSD incidence data. TSD carrier frequencies were then examined by single country and single region of origin in 28,029 Jews within this sample for whom such data were available for analysis. Jews with Polish and/or Russian ancestry constituted 88% of this sample and had a TSD carrier frequency of .0327. No TSD carriers were observed among the 166 Jews of Near Eastern origins. Relative to Jews of Polish and Russian origins, there was at least a twofold increase in the TSD carrier frequency in Jews of Austrian, Hungarian, and Czechoslovakian origins (P less than .005). These findings suggest that the TSD gene proliferated among the antecedents of modern Ashkenazi Jewry after the Second Diaspora (70 A.D.) and before their major migrations to regions of Poland and Russia (before 1100 A.D.).
Similar articles
-
Tay Sachs disease in Australia: reduced disease incidence despite stable carrier frequency in Australian Jews.Med J Aust. 2012 Dec 10;197(11):652-4. doi: 10.5694/mja12.11010. Med J Aust. 2012. PMID: 23230938
-
Heterozygote screening for Tay-Sachs disease: past successes and future challenges.Curr Opin Pediatr. 1996 Dec;8(6):625-9. doi: 10.1097/00008480-199612000-00014. Curr Opin Pediatr. 1996. PMID: 9018448 Review.
-
Tay-Sachs disease--carrier screening, prenatal diagnosis, and the molecular era. An international perspective, 1970 to 1993. The International TSD Data Collection Network.JAMA. 1993 Nov 17;270(19):2307-15. JAMA. 1993. PMID: 8230592
-
The frequency of Tay-Sachs disease causing mutations in the Brazilian Jewish population justifies a carrier screening program.Sao Paulo Med J. 2001 Jul 5;119(4):146-9. doi: 10.1590/s1516-31802001000400007. Sao Paulo Med J. 2001. PMID: 11500789 Free PMC article.
-
Tay-Sachs disease carrier screening: a model for prevention of genetic disease.Genet Test. 1998;2(4):271-92. doi: 10.1089/gte.1998.2.271. Genet Test. 1998. PMID: 10464605 Review.
Cited by
-
Infantile Monosialoganglioside2 (GM2) Gangliosidosis With Concurrent Bronchopneumonia: An Extraordinary Case of Tay-Sachs Disease.Cureus. 2024 Jan 7;16(1):e51797. doi: 10.7759/cureus.51797. eCollection 2024 Jan. Cureus. 2024. PMID: 38322066 Free PMC article.
-
Increased phosphorylation of HexM improves lysosomal uptake and potential for managing GM2 gangliosidoses.BBA Adv. 2021 Dec 13;2:100032. doi: 10.1016/j.bbadva.2021.100032. eCollection 2022. BBA Adv. 2021. PMID: 37082581 Free PMC article.
-
Multidimensional analysis and therapeutic development using patient iPSC-derived disease models of Wolfram syndrome.JCI Insight. 2022 Sep 22;7(18):e156549. doi: 10.1172/jci.insight.156549. JCI Insight. 2022. PMID: 36134655 Free PMC article.
-
Efficacy of a Bicistronic Vector for Correction of Sandhoff Disease in a Mouse Model.Mol Ther Methods Clin Dev. 2018 Oct 26;12:47-57. doi: 10.1016/j.omtm.2018.10.011. eCollection 2019 Mar 15. Mol Ther Methods Clin Dev. 2018. PMID: 30534578 Free PMC article.
-
Genetic diseases conferring resistance to infectious diseases.Genes Dis. 2015 Feb 25;2(3):247-254. doi: 10.1016/j.gendis.2015.02.008. eCollection 2015 Sep. Genes Dis. 2015. PMID: 30258868 Free PMC article. Review.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical